Regenxbio
RGNX
RGNX
187 hedge funds and large institutions have $1.23B invested in Regenxbio in 2019 Q4 according to their latest regulatory filings, with 33 funds opening new positions, 64 increasing their positions, 53 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
11% more funds holding
Funds holding: 168 → 187 (+19)
2.04% more ownership
Funds ownership: 79.46% → 81.5% (+2%)
32% less call options, than puts
Call options by funds: $8.09M | Put options by funds: $11.9M
Holders
187
Holding in Top 10
5
Calls
$8.09M
Puts
$11.9M
Top Buyers
| 1 | +$11M | |
| 2 | +$9.4M | |
| 3 | +$6.59M | |
| 4 |
WG
Winton Group
London,
United Kingdom
|
+$6.1M |
| 5 |
RG
Redmile Group
San Francisco,
California
|
+$5.98M |
Top Sellers
| 1 | -$39.1M | |
| 2 | -$9.69M | |
| 3 | -$9.07M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$5.88M |
| 5 |
VOYA Investment Management
Atlanta,
Georgia
|
-$5.19M |